Literature DB >> 9075466

The course of psychopathologic features in mild to moderate Alzheimer disease.

D P Devanand1, D M Jacobs, M X Tang, C Del Castillo-Castaneda, M Sano, K Marder, K Bell, F W Bylsma, J Brandt, M Albert, Y Stern.   

Abstract

BACKGROUND: The onset and course of the psychopathologic features of Alzheimer disease have not been established in prospective, longitudinal studies.
METHODS: Two hundred thirty-five patients with early, probable Alzheimer disease were recruited at 3 sites and observed naturalistically for up to 5 years. At 6-month intervals, the Columbia University Scale for Psychopathology in Alzheimer's Disease was administered. Markov analyses were used to predict the probability of a specific symptom developing or being maintained at the next visit. For each symptom category, the maximum frequency of occurrence at 4 consecutive points (duration, 2 years) was calculated.
RESULTS: Misidentification, wandering or agitation, and physical aggression increased during follow-up. At any visit, the likelihood of a new symptom developing was greatest for behavioral disturbance, intermediate for paranoid delusions and hallucinations, and least for depressed mood with vegetative features. Wandering or agitation occurred at 3 or more of 4 consecutive visits (duration, 2 years) in the majority of patients, paranoid delusions and hallucinations were intermediate in their degree of persistence, and depressed mood with vegetative signs rarely persisted.
CONCLUSIONS: Behavioral disturbance, particularly agitation, is common and persistent in patients with Alzheimer disease. Psychotic symptoms are less common and show moderate persistence over time. Depressed mood with vegetative signs is uncommon and rarely persists. These findings suggest leads about the optimal treatment duration for specific subtypes of psychopathologic features.

Entities:  

Mesh:

Year:  1997        PMID: 9075466     DOI: 10.1001/archpsyc.1997.01830150083012

Source DB:  PubMed          Journal:  Arch Gen Psychiatry        ISSN: 0003-990X


  58 in total

1.  Galantamine in the treatment of minor depression with mild to moderate Alzheimer's dementia in an elderly woman.

Authors:  Kannayiram Alagiakrishnan
Journal:  Prim Care Companion J Clin Psychiatry       Date:  2010

2.  Utilization of antihypertensives, antidepressants, antipsychotics, and hormones in Alzheimer disease.

Authors:  Carolyn W Zhu; Elayne E Livote; Kristin Kahle-Wrobleski; Nikolaos Scarmeas; Marilyn Albert; Jason Brandt; Deborah Blacker; Mary Sano; Yaakov Stern
Journal:  Alzheimer Dis Assoc Disord       Date:  2011 Apr-Jun       Impact factor: 2.703

Review 3.  Alzheimer's disease and mild cognitive impairment.

Authors:  Brendan J Kelley; Ronald C Petersen
Journal:  Neurol Clin       Date:  2007-08       Impact factor: 3.806

Review 4.  The ART of loss: Abeta imaging in the evaluation of Alzheimer's disease and other dementias.

Authors:  Victor L Villemagne; Michelle T Fodero-Tavoletti; Kerryn E Pike; Roberto Cappai; Colin L Masters; Christopher C Rowe
Journal:  Mol Neurobiol       Date:  2008-08-09       Impact factor: 5.590

5.  Lithium Treatment for Agitation in Alzheimer's disease (Lit-AD): Clinical rationale and study design.

Authors:  D P Devanand; Jesse G Strickler; Edward D Huey; Elizabeth Crocco; Brent P Forester; Mustafa M Husain; Ipsit V Vahia; Howard Andrews; Melanie M Wall; Gregory H Pelton
Journal:  Contemp Clin Trials       Date:  2018-05-31       Impact factor: 2.226

6.  Chronic divalproex sodium to attenuate agitation and clinical progression of Alzheimer disease.

Authors:  Pierre N Tariot; Lon S Schneider; Jeffrey Cummings; Ronald G Thomas; Rema Raman; Laura J Jakimovich; Rebekah Loy; Barbara Bartocci; Adam Fleisher; M Saleem Ismail; Anton Porsteinsson; Michael Weiner; Clifford R Jack; Leon Thal; Paul S Aisen
Journal:  Arch Gen Psychiatry       Date:  2011-08

7.  Risk Factors, Neuroanatomical Correlates, and Outcome of Neuropsychiatric Symptoms in Alzheimer's Disease.

Authors:  Stéphane P Poulin; David Bergeron; Bradford C Dickerson
Journal:  J Alzheimers Dis       Date:  2017       Impact factor: 4.472

8.  Neuropsychiatric symptoms in mild cognitive impairment: differences by subtype and progression to dementia.

Authors:  Emily R Edwards; Adam P Spira; Deborah E Barnes; Kristine Yaffe
Journal:  Int J Geriatr Psychiatry       Date:  2009-07       Impact factor: 3.485

Review 9.  The link between psychosis and aggression in persons with dementia: a systematic review.

Authors:  Denis Shub; Valdesha Ball; Asghar-Ali Ali Abbas; Aruna Gottumukkala; Mark E Kunik
Journal:  Psychiatr Q       Date:  2010-06

Review 10.  Structural neuroimaging in the detection and prognosis of pre-clinical and early AD.

Authors:  Christine Fennema-Notestine; Linda K McEvoy; Donald J Hagler; Mark W Jacobson; Anders M Dale
Journal:  Behav Neurol       Date:  2009       Impact factor: 3.342

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.